S.R. Aravind

618 total citations
16 papers, 490 citations indexed

About

S.R. Aravind is a scholar working on Plant Science, Biomaterials and Molecular Biology. According to data from OpenAlex, S.R. Aravind has authored 16 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Plant Science, 5 papers in Biomaterials and 4 papers in Molecular Biology. Recurrent topics in S.R. Aravind's work include Nanoparticle-Based Drug Delivery (5 papers), Polysaccharides and Plant Cell Walls (5 papers) and Graphene and Nanomaterials Applications (3 papers). S.R. Aravind is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Polysaccharides and Plant Cell Walls (5 papers) and Graphene and Nanomaterials Applications (3 papers). S.R. Aravind collaborates with scholars based in India, United States and United Arab Emirates. S.R. Aravind's co-authors include T.T. Sreelekha, Manu M. Joseph, Sheeja Varghese, Suraj K. George, S. Mini, K. Raveendran Pillai, Prabha Balaram, Lissy K. Krishnan, Wael M. Abdel‐Rahman and Vidhya Nair and has published in prestigious journals such as Carbohydrate Polymers, RSC Advances and World Journal of Gastroenterology.

In The Last Decade

S.R. Aravind

16 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.R. Aravind India 14 142 140 110 108 65 16 490
Fahimeh Salehi Iran 10 124 0.9× 168 1.2× 80 0.7× 91 0.8× 58 0.9× 13 497
Thaís Gomes de Carvalho Brazil 15 76 0.5× 161 1.1× 102 0.9× 61 0.6× 51 0.8× 22 584
Yuhua Ma China 12 185 1.3× 247 1.8× 98 0.9× 76 0.7× 62 1.0× 22 724
Xuehua Li China 13 89 0.6× 133 0.9× 107 1.0× 130 1.2× 83 1.3× 29 491
Chadarat Duangrat Thailand 6 94 0.7× 175 1.3× 108 1.0× 61 0.6× 27 0.4× 9 525
Vidhya Rekha Umapathy India 16 75 0.5× 122 0.9× 46 0.4× 97 0.9× 61 0.9× 47 504
Andreani D. Odysseos Cyprus 10 78 0.5× 137 1.0× 58 0.5× 131 1.2× 40 0.6× 17 604
Luana Roberta Michels Brazil 13 94 0.7× 126 0.9× 36 0.3× 81 0.8× 46 0.7× 20 489
Karolina Jafernik Poland 9 119 0.8× 202 1.4× 111 1.0× 54 0.5× 37 0.6× 17 511

Countries citing papers authored by S.R. Aravind

Since Specialization
Citations

This map shows the geographic impact of S.R. Aravind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Aravind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Aravind more than expected).

Fields of papers citing papers by S.R. Aravind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Aravind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Aravind. The network helps show where S.R. Aravind may publish in the future.

Co-authorship network of co-authors of S.R. Aravind

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Aravind. A scholar is included among the top collaborators of S.R. Aravind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Aravind. S.R. Aravind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Aravind, S.R., et al.. (2020). Sustained release of curcumin from fibrin matrix induces cancer cell death and immunomodulation. Biomedicine & Pharmacotherapy. 133. 110967–110967. 11 indexed citations
2.
Varghese, Sheeja, Manu M. Joseph, S.R. Aravind, et al.. (2019). Immunostimulatory plant polysaccharides impede cancer progression and metastasis by avoiding off-target effects. International Immunopharmacology. 73. 280–292. 19 indexed citations
3.
Abdel‐Rahman, Wael M., S.R. Aravind, Vidhya Nair, et al.. (2018). PO-001 Environmental toxins can transform mammary cells and induce chemo-resistance in breast cancer via multiple mechanisms. ESMO Open. 3. A21–A21. 9 indexed citations
4.
Abdel‐Rahman, Wael M., et al.. (2017). Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations. World Journal of Gastroenterology. 23(19). 3440–3440. 25 indexed citations
5.
Nair, Vidhya, et al.. (2017). The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells. Tumor Biology. 39(9). 3726133063–3726133063. 26 indexed citations
6.
Aravind, S.R. & Lissy K. Krishnan. (2016). Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties. International Immunopharmacology. 34. 78–85. 21 indexed citations
7.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2015). Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis. European Journal of Pharmaceutics and Biopharmaceutics. 93. 183–195. 23 indexed citations
8.
Kumar, Santosh, et al.. (2015). Asarones from Acorus calamus in Combination with Azoles and Amphotericin B: A Novel Synergistic Combination to Compete Against Human Pathogenic Candida Species In Vitro. Applied Biochemistry and Biotechnology. 175(8). 3683–3695. 15 indexed citations
9.
Joseph, Manu M., et al.. (2014). Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors. Translational Oncology. 7(5). 525–536. 24 indexed citations
10.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2014). Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma. Colloids and Surfaces B Biointerfaces. 116. 219–227. 25 indexed citations
11.
Aravind, S.R., Manu M. Joseph, Suraj K. George, et al.. (2014). TRAIL-based tumor sensitizing galactoxyloglucan, a novel entity for targeting apoptotic machinery. The International Journal of Biochemistry & Cell Biology. 59. 153–166. 23 indexed citations
12.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2014). Galactoxyloglucan-Modified Nanocarriers of Doxorubicin for Improved Tumor-Targeted Drug Delivery with Minimal Toxicity. Journal of Biomedical Nanotechnology. 10(11). 3253–3268. 52 indexed citations
13.
Aravind, S.R., T.T. Sreelekha, Bhuvnesh Kumar, Satish Kumar, & C. Mohandas. (2014). Characterization of three depside compounds from a Western Ghat lichen Parmelia erumpens Kurok with special reference to antimicrobial and anticancer activity. RSC Advances. 4(65). 34632–34632. 16 indexed citations
14.
Joseph, Manu M., S.R. Aravind, Suraj K. George, Sheeja Varghese, & T.T. Sreelekha. (2013). A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity. Carbohydrate Polymers. 98(2). 1466–1475. 85 indexed citations
15.
Joseph, Manu M., S.R. Aravind, Sheeja Varghese, S. Mini, & T.T. Sreelekha. (2012). PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties. Colloids and Surfaces B Biointerfaces. 104. 32–39. 62 indexed citations
16.
Aravind, S.R., Manu M. Joseph, Sheeja Varghese, Prabha Balaram, & T.T. Sreelekha. (2012). Antitumor and Immunopotentiating Activity of Polysaccharide PST001 Isolated from the Seed Kernel ofTamarindus indica: An In Vivo Study in Mice. The Scientific World JOURNAL. 2012. 1–14. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026